1 results match your criteria: "India. Electronic address: anita.roy@bioschool.iitd.ac.in.[Affiliation]"
A pre-B acute lymphoblastic leukemia cell line model reveals the mechanism of thalidomide therapy-related B-cell leukemogenesis.
J Biol Chem
August 2024
Kusuma School of Biological Sciences, Indian Institute of Technology, New Delhi, India. Electronic address:
Lenalidomide, a thalidomide derivative, is prescribed as maintenance therapy for multiple myeloma (MM). Patients with MM receiving lenalidomide were found to develop a distinct therapy-related B cell acute lymphoblastic leukemia (B-ALL). However, the molecular mechanism by which lenalidomide drives B-ALL is unknown.
View Article and Find Full Text PDF